This GitHub repository contains the source code for the Udacity course "AI Programming with Python Nanodegree Program." Here, I utilize a pre-trained image classifier to identify dog breeds and create ...

Lord Ganesha is one of the most revered deities of the Hindu culture, worshipped across the globe. Ganesh Chaturthi or Vinayak Chaturthi is a festival that marks his birth celebration across 10 days, ...

For the past few years, a small team of health scientists at the Centers for Disease Control and Prevention had been tasked with answering basic statistical questions like: Who is drowning? Where is ...

A new Stanford University study suggests that the number of entry-level programming jobs in the U.S. has declined significantly since the launch of ChatGPT. The paper was published today by three ...

Stellantis shelves AutoDrive Level 3 system due to concerns around cost, market viability, sources say Level 3 allows hands-free and eyes-off driving under certain conditions Company says Level 3 ...

A federal-state partnership that monitors for foodborne illnesses quietly scaled back its operations nearly two months ago. As of July 1, the Foodborne Diseases Active Surveillance Network (FoodNet) ...

The U.S. Visa Waiver Program is a federal program of the United States. It enables citizens of few selected countries to travel to the United States for business or tourism for up to 90 days without a ...

What is the best career fit for me? Take our assessment now. Finding your dream job starts with knowing what makes you the way you are. Simple Statements that relate to you. Unique Be yourself, answer ...

Microsoft has been adding new security features to Windows with every update. Windows 11/10 comes with superlative security features as opposed to the earlier versions of the software. Firewall ...

Some Windows 11/10 users have reported that after launching a program, it runs but doesn’t show up on the screen. The users can see the program on their Taskbar or the Task Manager, but it is not ...

AbbVie has written the next chapter in its epic quest to treat psychiatric disorders, agreeing to buy a psychedelic drug candidate from Gilgamesh Pharmaceuticals for up to $1.2 billion. Bloomberg ...